-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2024-10-30
MNULF:OTC-MNULF (USD)
COMMON STOCK | REIT - Office |
Last Closing
USD 0.0013Change
0.00 (0.00)%Market Cap
USD 0.11BVolume
N/AAnalyst Target
N/AVerdict
Verdict
Values as of: 2024-10-30
COMMON STOCK | REIT - Office |
Last Closing
USD 0.0013Change
0.00 (0.00)%Market Cap
USD 0.11BVolume
N/AAnalyst Target
N/AVerdict
Verdict
Manulife US Real Estate Investment Trust ("Manulife US REIT" or "MUST") is the first pure-play U.S. office REIT listed in Asia. It is a Singapore listed REIT established with the investment strategy principally to invest, directly or indirectly, in a portfolio of income-producing office real estate in key markets in the United States ("U.S."), as well as real estate-related assets. MUST's portfolio comprises 10 freehold office properties in Arizona, California, Georgia, New Jersey, Virginia and Washington D.C. The current portfolio has an aggregate net lettable area of 5.1 million sq ft and was last independently valued at US$1.4 billion as at 31 December 2023.
Company Website : https://www.manulifeusreit.sg
Currency: USD
Country : USA
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
MPCMF | Mapletree Commercial Trust |
N/A |
USD 5.68B |
DEXSF | DEXUS |
N/A |
USD 5.23B |
DWVYF | Derwent London PLC |
N/A |
USD 3.30B |
KREVF | Keppel REIT |
N/A |
USD 2.94B |
APYRF | Allied Properties Real Estate .. |
N/A |
USD 2.01B |
GPEAF | Great Portland Estates Plc |
N/A |
USD 1.79B |
WKPPF | Workspace Group plc |
N/A |
USD 1.69B |
CLIHF | CLS Holdings plc |
N/A |
USD 0.72B |
TUERF | True North Commercial Real Est.. |
N/A |
USD 0.14B |
SLTTF | Slate Office REIT |
N/A |
USD 0.04B |
N/A
Market Performance vs. Industry/Classification (REIT - Office) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Trailing 12 Months | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Trailing 5 Years | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | N/A | N/A | N/A | N/A | N/A | ||
Risk Adjusted Return | N/A | N/A | N/A | N/A | N/A | ||
Market Capitalization | 0.11B | 18% | F | 58% | F |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
The company had positive total cash flow in the most recent four quarters.
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
The company had negative total free cash flow in the most recent four quarters.
This stock has shown below median revenue growth in the previous 5 years compared to its sector